Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malaria

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 77 articles:
HTML format
Text format



Single Articles


    May 2017
  1. SEPULVEDA N, Manjurano A, Campino SG, Lemnge M, et al
    Malaria host candidate genes validated by association with current, recent and historic measures of transmission intensity.
    J Infect Dis. 2017 May 25. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  2. GATTON ML, Dunn J, Chaudhry A, Ciketic S, et al
    Use of PfHRP2-only RDTs rapidly select for PfHRP2-negative parasites with serious implications for malaria case management and control.
    J Infect Dis. 2017 Mar 8. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. LO E, Lam N, Hemming-Schroeder E, Nguyen J, et al
    Frequent Spread of Plasmodium vivax Malaria Maintains High Genetic Diversity at the Myanmar-China Border without Distance and Landscape Barriers.
    J Infect Dis. 2017 Mar 3. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2017
  4. TER KUILE FO, Taylor SM
    Gilding the lily?: Enhancing antenatal malaria prevention in HIV-infected women.
    J Infect Dis. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format    


  5. NATUREEBA P, Kakuru A, Muhindo M, Littmann E, et al
    Intermittent Preventive Treatment with Dihydroartemisinin-piperaquine for the Prevention of Malaria among HIV-infected Pregnant Women.
    J Infect Dis. 2017 Feb 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. KANA IH, Adu B, Tiendrebeogo RW, Singh SK, et al
    Naturally Acquired Antibodies Target the Glutamate-Rich Protein on Intact Merozoites and Predict Protection Against Febrile Malaria.
    J Infect Dis. 2017 Feb 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. TUMWEBAZE P, Tukwasibwe S, Taylor A, Conrad M, et al
    Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.
    J Infect Dis. 2017;215:631-635.
    PubMed     Text format     Abstract available


  8. LUBIS IN, Wijaya H, Lubis M, Lubis CP, et al
    Contribution of Plasmodium knowlesi to multi-species human malaria infections in North Sumatera, Indonesia.
    J Infect Dis. 2017 Feb 13. doi: 10.1093.
    PubMed     Text format    


    January 2017
  9. HOBBS CV, Anderson C, Neal J, Sahu T, et al
    Trimethoprim-Sulfamethoxazole Prophylaxis During Live Malaria Sporozoite Immunization Induces Long-Lived, Homologous, and Heterologous Protective Immunity Against Sporozoite Challenge.
    J Infect Dis. 2017;215:122-130.
    PubMed     Text format     Abstract available


  10. OTTICHILO RK, Polyak CS, Guyah B, Singa B, et al
    Malaria Parasitemia and Parasite Density in Antiretroviral-Treated HIV-Infected Adults Following Discontinuation of Cotrimoxazole Prophylaxis.
    J Infect Dis. 2017;215:88-94.
    PubMed     Text format     Abstract available


    December 2016
  11. THOMSEN EK, Koimbu G, Pulford J, Jamea-Maiasa S, et al
    Mosquito behaviour change after distribution of bednets results in decreased protection against malaria exposure.
    J Infect Dis. 2016 Dec 22. pii: jiw615. doi: 10.1093.
    PubMed     Text format     Abstract available


  12. ALKAITIS MS, Wang H, Ikeda AK, Rowley CA, et al
    Decreased Rate of Plasma Arginine Appearance in Murine Malaria May Explain Hypoargininemia in Children With Cerebral Malaria.
    J Infect Dis. 2016;214:1840-1849.
    PubMed     Text format     Abstract available


  13. EISELE TP, Bennett A, Silumbe K, Finn TP, et al
    Short-term Impact of Mass Drug Administration With Dihydroartemisinin Plus Piperaquine on Malaria in Southern Province Zambia: A Cluster-Randomized Controlled Trial.
    J Infect Dis. 2016;214:1831-1839.
    PubMed     Text format     Abstract available


  14. CHEN I, Gosling R, Drakeley C, Bousema T, et al
    Mass Drug Administration for Malaria: A Means to What end?
    J Infect Dis. 2016;214:1790-1792.
    PubMed     Text format    


  15. YA-UMPHAN P, Cerqueira D, Parker DM, Cottrell G, et al
    Anopheles Salivary Biomarker to Assess Malaria Transmission Risk Along the Thailand-Myanmar Border.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    November 2016
  16. SILTERRA J, Gillette MA, Lanaspa M, Pelle KG, et al
    Transcriptional categorization of the etiology of pneumonia syndrome in pediatric patients in malaria endemic areas.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    September 2016
  17. HOU N, Zou Y, Piao X, Liu S, et al
    T Cell Immunoglobulin- and Mucin-Domain-Containing Molecule-3 (Tim-3) Signalling Blockade Improves Cell-Mediated Immunity Against Malaria.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  18. PETERSON I, Bar-Zeev N, Kennedy N, Ho A, et al
    Respiratory virus-associated severe acute respiratory illness (SARI) and viral clustering in Malawian children in a setting with a high prevalence of HIV, malaria and malnutrition.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  19. BARBER BE, William T, Grigg MJ, Piera KA, et al
    Nitric oxide dependent endothelial dysfunction and reduced arginine bioavailability in vivax malaria but no greater increase in intravascular haemolysis in severe disease.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  20. NICOLETE VC, Frischmann S, Barbosa S, King CL, et al
    Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein Are Associated with Clinical Immunity to Malaria in Rural Amazonians.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  21. REYNALDI A, Schlub TE, Piriou E, Ogolla S, et al
    Modeling of EBV infection and antibody responses in Kenyan infants with different levels of malaria exposure shows maternal antibody decay is a major determinant of early EBV infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  22. BOYCE R, Reyes R, Matte M, Ntaro M, et al
    Severe flooding and malaria transmission in the Western Ugandan highlands: Implications for disease control in an era of global climate change.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  23. ELPHINSTONE RE, Conroy AL, Hawkes M, Hermann L, et al
    Alterations in systemic extracellular heme and hemopexin are associated with adverse clinical outcomes in Ugandan children with severe malaria.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  24. BRIAND V, Saal J, Ghafari C, Huynh BT, et al
    Fetal Growth Restriction Is Associated With Malaria in Pregnancy: A Prospective Longitudinal Study in Benin.
    J Infect Dis. 2016;214:417-25.
    PubMed     Text format     Abstract available


  25. RODRIGUEZ-BARRAQUER I, Arinaitwe E, Jagannathan P, Boyle MJ, et al
    Quantifying heterogeneous malaria exposure and clinical protection in a cohort of Ugandan children.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    July 2016
  26. TCHAPARIAN E, Sambol NC, Arinaitwe E, McCormack SA, et al
    Population pharmacokinetics and pharmacodynamics of lumefantrine in young Ugandan children treated with artemether-lumefantrine for uncomplicated malaria.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    June 2016

  27. Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01.
    J Infect Dis. 2016.
    PubMed     Text format    


  28. RAMPLING T, Ewer KJ, Bowyer G, Bliss CM, et al
    Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B with ChAd-MVA Vectored Vaccines Expressing ME-TRAP.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  29. REGULES JA, Cicatelli SB, Bennett JW, Paolino KM, et al
    Fractional third and fourth dose of RTS,S/AS01 malaria candidate vaccine: a phase 2a controlled human malaria infection and immunogenicity study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    May 2016
  30. DORITCHAMOU JY, Herrera R, Aebig JA, Morrison R, et al
    VAR2CSA domain-specific analysis of naturally acquired functional antibodies to P. falciparum placental malaria.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    March 2016
  31. BECK HP, Wampfler R, Carter N, Koh G, et al
    Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping.
    J Infect Dis. 2016;213:794-9.
    PubMed     Text format     Abstract available


    February 2016
  32. KATRAK S, Day N, Ssemmondo E, Kwarisiima D, et al
    Community-wide prevalence of malaria parasitemia in HIV-infected and uninfected populations in a high transmission setting in Uganda.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  33. GONCALVES BP, Drakeley C, Bousema T
    Infectivity of microscopic and submicroscopic malaria infections in low endemic settings.
    J Infect Dis. 2016.
    PubMed     Text format    


  34. LIN JT, Meshnick SR, Saunders DL, Lon C, et al
    Infectivity of microscopic and submicroscopic malaria infections in low endemic settings.
    J Infect Dis. 2016.
    PubMed     Text format    


  35. PAYNE RO, Milne KH, Elias SC, Edwards NJ, et al
    Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  36. GUTMAN J, Taylor S, Meshnick SR, Ter Kuile FO, et al
    Reply to Harrington et al.
    J Infect Dis. 2016;213:497-8.
    PubMed     Text format    


  37. HARRINGTON WE, Fried M, Duffy PE
    Defending the Use of Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment for Malaria in Pregnancy: A Short-Sighted Strategy.
    J Infect Dis. 2016;213:496-7.
    PubMed     Text format    


    December 2015
  38. CHENET SM, Akinyi Okoth S, Huber CS, Chandrabose J, et al
    Independent Emergence of the Plasmodium Falciparum Kelch Propeller Domain Mutant Allele C580Y in Guyana.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  39. IMWONG M, Stepniewska K, Tripura R, Peto TJ, et al
    The numerical distributions of parasite densities in asymptomatic malaria.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  40. GOVINDASAMY G, Barber BE, Ghani SA, William T, et al
    Retinal changes in uncomplicated and severe Plasmodium knowlesi malaria.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  41. FARRINGTON LA, Jagannathan P, McIntyre TI, Vance HM, et al
    Frequent malaria drives progressive Vdelta2 T cell loss, dysfunction, and CD16 upregulation during early childhood.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  42. LIN JT, Ubalee R, Lon C, Balasubramanian S, et al
    Microscopic Plasmodium falciparum gametocytemia and infectivity to mosquitoes in Cambodia.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  43. URSING J, Rombo L, Bergqvist Y, Rodrigues A, et al
    High dose chloroquine can be used for treatment of chloroquine resistant Plasmodium falciparum malaria.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  44. STRESMAN GH, Baidjoe AY, Stevenson J, Grignard L, et al
    Focal Screening to Identify the Subpatent Parasite Reservoir in an Area of Low and Heterogeneous Transmission in the Kenya Highlands.
    J Infect Dis. 2015;212:1768-77.
    PubMed     Text format     Abstract available


    November 2015
  45. YEKA A, Kigozi R, Conrad MD, Lugemwa M, et al
    Artesunate/amodiaquine versus artemether/lumefantrine for the treatment of uncomplicated malaria in Uganda: a randomized trial.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  46. REYNALDI A, Schlub TE, Chelimo K, Sumba PO, et al
    The impact of malaria co-infections on longitudinal Epstein-Barr virus kinetics in Kenyan children.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    October 2015
  47. VAN SCHALKWYK DA, Nash MN, Shafik SH, Summers RL, et al
    Verapamil-sensitive transport of quinacrine and methylene blue via mutant PfCRT reduces the malaria parasite's susceptibility to these tricyclic drugs.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  48. ISHIOKA H, Ghose A, Charunwatthana P, Maude R, et al
    Sequestration and Red Cell Deformability as determinants of hyperlactataemia in falciparum malaria.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  49. FORNACE KM, Nuin NA, Betson M, Grigg MJ, et al
    Asymptomatic and submicroscopic carriage of Plasmodium knowlesi malaria in household and community members of clinical cases in Sabah, Malaysia.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    September 2015
  50. LIN JT, Hathaway NJ, Saunders DL, Lon C, et al
    Using Amplicon Deep Sequencing to Detect Genetic Signatures of Plasmodium vivax Relapse.
    J Infect Dis. 2015;212:999-1008.
    PubMed     Text format     Abstract available


  51. MEJIA P, Diez-Silva M, Kamena F, Lu F, et al
    Human C1-Inhibitor suppresses malaria parasite invasion and cytoadhesion via binding to parasite glycosylphosphatidylinositol and host cell receptors.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  52. ARTIMOVICH E, Schneider K, Taylor TE, Kublin JG, et al
    Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi.
    J Infect Dis. 2015;212:694-701.
    PubMed     Text format     Abstract available


    August 2015
  53. -ASCOFARE OM, May J
    Is A578S SNP in K13-propeller a marker of emerging Plasmodium falciparum artemisinin-resistance in Africa?
    J Infect Dis. 2015.
    PubMed     Text format    


  54. ATWELL JE, Thumar B, Robinson LJ, Tobby R, et al
    Impact of placental malaria and hypergammaglobulinemia on transplacental transfer of respiratory syncytial virus antibody in Papua New Guinea.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    July 2015
  55. KEPHA S, Nuwaha F, Nikolay B, Gichuki P, et al
    Effect of repeated anthelminthic treatment on malaria in school children in Kenya: a randomized, open label, equivalence trial.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  56. OUEDRAOGO AL, Goncalves BP, Gneme A, Wenger EA, et al
    Dynamics of the human infectious reservoir for malaria determined by mosquito feeding assays and ultra-sensitive malaria diagnosis in Burkina Faso.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  57. ZHANG R, Suwanarusk R, Malleret B, Cooke BM, et al
    A basis for rapid clearance of circulating ring-stage malaria parasites by the spiroindolone KAE609.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  58. YEO TW, Anstey NM
    Reply to Eisenhut.
    J Infect Dis. 2015;212:168.
    PubMed     Text format    


    May 2015
  59. COSTA PA, Leoratti FM, Figueiredo MM, Tada MS, et al
    Induction of inhibitory receptors on T cells during Plasmodium vivax malaria impairs cytokine production.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  60. TRAVASSOS MA, Coulibaly D, Laurens MB, Dembele A, et al
    Hemoglobin C trait provides protection from clinical falciparum malaria in Malian children.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  61. DAUD II, Coleman CB, Smith NA, Ogolla S, et al
    Breast-Milk as a Potential Source of Epstein-Barr Virus Transmission among Infants Living in a Malaria Endemic Region of Kenya.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  62. BERG A, Otterdal K, Patel S, Gonca M, et al
    Complement activation correlates to disease severity and contribute to cytokine response in falciparum malaria.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  63. HSIANG MS, Greenhouse B, Rosenthal PJ
    Reply to Goyal et al.
    J Infect Dis. 2015;211:1687.
    PubMed     Text format    


    April 2015
  64. HUANG F, Takala-Harrison S, Jacob CG, Liu H, et al
    A single mutation in K13 predominates in Southern China and is associated with delayed clearance of Plasmodium falciparum following artemisinin treatment.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  65. MENSAH-BROWN HE, Amoako N, Abugri J, Stewart LB, et al
    Analysis of erythrocyte invasion mechanisms of Plasmodium falciparum clinical isolates across three endemic areas within one country.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  66. ZEESHAN M, Tyagi RK, Tyagi K, Alam MS, et al
    Host-parasite interaction: selective Pv-fam-a family proteins of Plasmodium vivax bind to a restricted number of human erythrocyte receptors.
    J Infect Dis. 2015;211:1111-20.
    PubMed     Text format     Abstract available


    March 2015
  67. BERNA AZ, McCarthy JS, Wang XR, Saliba KJ, et al
    Biomarkers of infection with Plasmodium falciparum detected in human breath.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  68. ESPINOSA DA, Gutierrez GM, Rojas-Lopez M, Noe AR, et al
    Proteolytic Cleavage of the P. falciparum Circumsporozoite Protein is a Target of Protective Antibodies.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    February 2015
  69. MANGANO VD, Kabore Y, Bougouma EC, Verra F, et al
    Novel insights into the protective role of haemoglobin S and C against Plasmodium falciparum parasitaemia.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  70. HUSON MA, Wouters D, van Mierlo G, Grobusch MP, et al
    HIV co-infection enhances complement activation during sepsis.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  71. BOYLE MJ, Jagannathan P, Bowen K, McIntyre TI, et al
    The effector phenotype of P. falciparum-specific CD4 T cells is influenced by both age and transmission intensity in naturally exposed populations.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    January 2015
  72. GUTMAN J, Kalilani L, Taylor S, Zhou Z, et al
    Plasmodium falciparum dihydropteroate synthetase-A581G mutation reduces effectiveness of sulfadoxine-pyrimethamine preventive therapy in Malawian pregnant women.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    November 2014
  73. TORRES KJ, Castrillon CE, Moss EL, Saito M, et al
    Genome-Level Determination of Plasmodium falciparum Blood Stage Targets of Malarial Clinical Immunity in the Peruvian Amazon.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


  74. KAMAU E, Campino S, Amenga-Etego L, Drury E, et al
    K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


    October 2014
  75. GULLINGSRUD J, Milman N, Saveria T, Chesnokov O, et al
    High throughput screening platform identifies small molecules that prevent sequestration of Plasmodium falciparum-infected erythrocytes.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


  76. LUKENS AK, Heidebrecht RW Jr, Mulrooney C, Beaudoin JA, et al
    Diversity-Oriented Synthesis probe targets Plasmodium falciparum cytochrome b ubiquinone reduction site and synergizes with oxidation site inhibitors.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


  77. OBALDIA N 3RD, Baro NK, Calzada JE, Santamaria AM, et al
    Clonal outbreak of Plasmodium falciparum in eastern Panama.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malaria is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: